PBT fell 34% as revenue rose 17.8%; tax credit masked the NPAT drop

What changed

Continuing-operations revenue rose 17.8% to $323.0m and Operating EBITDA lifted 7.8% to $146.3m, but profit before tax fell 34.0% to $143.4m. Reported NPAT declined only 3.8% to $186.7m because a $43.3m tax credit replaced a $23.3m tax expense in HY23 — a swing in effective tax rate from -10.7% to +30.2% in the company's favour at the bottom line. Underlying profit was essentially flat at $139.2m (+0.3%).

Operating cash flow jumped 38.7% to $337.9m, with PPE capex cut to $131.2m from $191.9m, lifting pre-lease free cash flow to $206.7m. Management's own non-GAAP free cash flow figure was still negative at -$158.4m, but improved by $138.5m year on year. Gross borrowings fell $526.3m to $2.5b, equity rose 34.1% to $4.9b (consistent with a capital raise during the period), and the interim dividend was cut to nil from 8.8c.

What matters

• The operating read is much weaker than the reported NPAT suggests. PBT fell 34% on 17.8% revenue growth — operating leverage went in the wrong direction. NPAT only held up because of a $43.3m tax credit, which is not a recurring earnings driver. Underlying profit at +0.3% is the more honest signal.
• Balance sheet has clearly been deleveraged, but at shareholders' expense. Gross debt down $526.3m, equity up $1.2b, gearing back inside the 33.6% medium-term band, and cash up to $33.3m. Combined with the suspended dividend, this looks like a deliberate balance-sheet repair financed by equity issuance and retained cash, not by trading earnings.
• Segment margins compressed in both geographies. New Zealand's inferred segment margin fell from ~53.4% to ~48.3% even as revenue grew, and Australia's segment result fell to $56.0m from $65.3m despite revenue rising 57.6% to $52.5m. Mix shifted toward Australia (16.3% of revenue from 12.2%), but the dominant NZ engine got less profitable per dollar of revenue.

Expectations

No explicit quantitative guidance, forward sales/work balance, or full-year target was disclosed in the extracted material, and there is no FY23 anchor in this dataset against which to test second-half shape. Management reiterated only the medium-term gearing target (33.6%, within range) and confirmed no interim dividend.

What the release does support: a stronger, less levered balance sheet and improving cash generation. What it does not support: a clean recovery in trading profitability, given PBT down 34% and segment margins easing in both NZ and Australia.

Quality of result

Mixed, leaning low-quality at the headline.

• The 3.8% NPAT decline is flattered by a one-off-shaped tax credit; PBT down 34% is the cleaner operating read and is consistent with the flat underlying profit.
• Operating cash flow of $337.9m is 231% of EBITDA, which is unusually high and points to working-capital release rather than core trading. Receivables days fell sharply (~525 to ~382), and trade receivables on the balance sheet collapsed from $791.9m to a near-zero $0.0m line — a classification or settlement effect that needs explanation before this OCF lift can be treated as durable.
• The capex cut to $131.2m from $191.9m helped pre-lease FCF mechanically; whether this is a deliberate slowdown in development or a timing gap is not disclosed.
• Equity uplift of $1.2b versus retained earnings of $186.7m points to capital raised, so per-share metrics will look weaker than absolute movements suggest.

Unresolved

• What drove the $43.3m tax credit, and is any portion structurally repeatable?
• What reconciles reported NPAT of $186.7m to underlying profit of $139.2m — i.e. the ~$47.5m of fair-value or non-underlying items?
• What sits inside the non-GAAP free cash flow of -$158.4m beyond the $131.2m PPE line — development land, acquisitions, capitalised interest?
• Why did the trade receivables line fall from $791.9m to effectively zero, and how much of the OCF beat is a reclassification rather than genuine cash collection?
• Was the equity uplift a placement/rights issue, and at what dilution? The extracted material does not quantify shares issued.
• When does the board expect to resume dividends, given gearing is now inside the target band?

This briefing cannot assess unit-level metrics (occupancy, resale margins, new sales volumes, embedded value) or any market-price-based valuation, as neither was provided in the extracted data.

Key metrics

Segment breakdown

Analytical metrics

---

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.